BRIEF-Corpay Inc - Corpay Signs Definitive Agreement To Acquire Gps Capital Markets For $725 Million-March 2024-www.financetom.com

BRIEF-Corpay Inc - Corpay Signs Definitive Agreement To Acquire Gps Capital Markets For $725 Million

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Corpay Inc - Corpay Signs Definitive Agreement To Acquire Gps Capital Markets For $725 Million

Jun 19, 2024 2:33 PM

June 19 (Reuters) - Corpay Inc ( CPAY ):

* CORPAY INC ( CPAY ) - CORPAY SIGNS DEFINITIVE AGREEMENT TO ACQUIRE

GPS

CAPITAL MARKETS FOR $725 MILLION

Source text for Eikon:

Further company coverage:

Previous page： Uber beats third-quarter profit estimates, gross bookings growth slows Next page： --Nasdaq Futures Sink Premarket as Microsoft, Meta Drop Following Quarterly Results Late Wednesday

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Uber beats third-quarter profit estimates, gross bookings growth slows

Oct 31, 2024

* Gross bookings forecast slightly below estimates * Net income includes $1.7 billion pre-tax gain * Q3 revenue beats estimates on lower driver incentives, refunds Oct 31 (Reuters) - Uber Technologies ( UBER ) edged past quarterly profit estimates but gross bookings grew at its slowest pace in over a year, suggesting riders were opting for less expensive public transportation...

--Nasdaq Futures Sink Premarket as Microsoft, Meta Drop Following Quarterly Results Late Wednesday

Oct 31, 2024

06:57 AM EDT, 10/31/2024 (MT Newswires) -- Price: 415.65, Change: -16.88, Percent Change: -3.90 ...

Cenovus Energy's Q3 Earnings, Revenue Fall

Oct 31, 2024

06:56 AM EDT, 10/31/2024 (MT Newswires) -- Cenovus Energy ( CVE ) reported Q3 earnings Thursday of 0.42 Canadian dollars ($0.30) per diluted share, down from CA$0.97 a year earlier. Analysts polled by Capital IQ expected CA$0.52. Gross sales for the quarter ended Sept. 30 was CA$17.49 billion, down from CA$18.44 billion. Two analysts surveyed by Capital IQ expected CA$14.69...

Bristol Myers Q3 earnings beat expectations, helped by sales of older drugs

Oct 31, 2024

Oct 31 (Reuters) - Bristol Myers Squibb ( BMY ) posted better-than-expected third-quarter earnings on Thursday citing strong sales of established drugs like blood thinner Eliquis and cancer treatment Revlimid as well as newer drugs like heart treatment Camzyos and cancer cell therapy Breyanzi. The drugmaker said it earned $3.7 billion in the quarter, or $1.80 per share, compared with...